pancreatic cancer
Showing NaN - NaN of 52
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen
Recruiting
- Pancreatic Cancer
- +3 more
- Bio-specimen Collection: Blood
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in United States (drug,
Recruiting
- Pancreatic Adenosquamous Carcinoma
- +2 more
- Oxaliplatin
- +5 more
-
Mobile, Alabama
- +182 more
Aug 1, 2022
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Rochester (SX-682, Nivolumab Injectable Product)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Cancer
- SX-682
- Nivolumab Injectable Product
-
Rochester, New YorkUniversity of Rochester
Dec 14, 2021
Collecting Medical Information and Tissue Samples From
Recruiting
- Islet Cell Tumor
- +2 more
- medical chart review
- +2 more
-
Rochester, MinnesotaMayo Clinic Cancer Center
Sep 28, 2021
Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in Worldwide (IMMU-107, , Gemcitabine)
Terminated
- Metastatic Pancreatic Cancer
- Pancreatic Cancer
- IMMU-107
- +2 more
-
Gilbert, Arizona
- +64 more
Aug 12, 2021
Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)
Completed
- Liver Cancer
- +9 more
- Early palliative care
-
La Jolla, California
- +22 more
Jul 22, 2021
Advanced Solid Tumors, Solid Tumors, Pancreatic Cancer Trial in Rochester, Saint Louis (Defactinib, Pembrolizumab, Gemcitabine)
Completed
- Advanced Solid Tumors
- +2 more
- Defactinib
- +2 more
-
Rochester, Minnesota
- +1 more
Jul 18, 2021
Pancreatic Cancer Trial in United States (biological, drug, radiation)
Completed
- Pancreatic Cancer
- HyperAcute-Pancreas Immunotherapy
- +2 more
-
Birmingham, Alabama
- +74 more
May 26, 2020
Pancreatic Cancer Trial in Worldwide (erlotinib HCl, gemcitabine HCl)
Completed
- Pancreatic Cancer
- erlotinib hydrochloride
- gemcitabine hydrochloride
-
Tucson, Arizona
- +172 more
Mar 31, 2020
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (Rucaparib)
Completed
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
-
Los Angeles, California
- +7 more
Jan 21, 2020
Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)
Pancreatic Cancer Trial in Jacksonville, Rochester (LY2090314, FOLFOX, Gemcitabine)
Breast Cancer, Lung Cancer, Pancreatic Cancer Trial in United States (INO-1400, INO-9012, INO-1401)
Completed
- Breast Cancer
- +8 more
- INO-1400
- +2 more
-
Detroit, Michigan
- +5 more
Nov 15, 2018
Pancreatic Cancer, Non-Small-Cell Lung Cancer Trial in Rochester (Dignity Therapy)
Completed
- Pancreatic Cancer
- Non-Small-Cell Lung Cancer
- Dignity Therapy
-
Rochester, MinnesotaMayo Clinic
Mar 19, 2018